KLS 0611Alternative Names: KLS-0611
Latest Information Update: 07 Jul 2008
At a glance
- Originator Kissei Pharmaceutical
- Mechanism of Action Mucin stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Clinical Phase Unknown Dry eyes